China’s NHSA to expand collective drug procurement, curb bid-rigging

TREE NEWS update: China’s National Healthcare Security Administration will expand the scope of centralized drug and medical consumable procurement, guided by the principle of “new drugs not procured, procured drugs not new.” It will include more high-volume, overpriced products and deepen efforts in traditional Chinese medicine, biologics, and consumables to reduce patient costs. Procurement rules will be optimized to prevent bid-rigging and promote fair, rational competition.